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Abstract
Mammalian models, most notably the mouse and ferret, have been instrumental in the assessment 
of avian influenza virus pathogenicity and transmissibility, and have been used widely to 
characterize the molecular determinants that confer H5N1 virulence in mammals. However, while 
H7 influenza viruses have typically been associated with conjunctivitis and/or mild respiratory 
disease in humans, severe disease and death is also possible, as underscored by the recent 
emergence of H7N9 viruses in China. Despite the public health need to understand the pandemic 
potential of this virus subtype, H7 virus pathogenesis and transmission has not been as extensively 
studied. In this review, we discuss the heterogeneity of H7 subtype viruses isolated from humans, 
and the characterization of mammalian models to study the virulence of H7 subtype viruses 
associated with human infection, including viruses of both high and low pathogenicity and 
following multiple inoculation routes. The use of the ferret transmission model to assess the 
influence of receptor binding preference among contemporary H7 influenza viruses is described. 
These models have enabled the study of preventative and therapeutic agents, including vaccines 
and antivirals, to reduce disease burden, and have permitted a greater appreciation that not all 
highly pathogenic influenza viruses are created equal.
1 Introduction
The emergence in Spring 2013 of a low pathogenic avian influenza (LPAI) H7N9 virus in 
Southeast Asia, capable of causing severe human disease and death, resulted in rapid global 
recognition of the pandemic potential of H7 viruses. H7N9 viruses are second only to H5N1 
viruses in total confirmed human cases and fatalities from avian influenza viruses, though 
different epidemiologic profiles make it difficult to draw extensive parallels between these 
viruses (Cowling et al. 2013), necessitating increased investigation of H7 subtype virus 
virulence. However, this was not the first instance of human infection caused by an H7 
subtype virus; prior to this outbreak, there were >100 confirmed or presumed human 
infections with H7 viruses in both Europe and the Americas (Belser et al. 2009a). Similar to 
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H5N1, human-to-human transmission of H7 viruses has been rare but documented (Abdel-
Ghafar et al. 2008; Koopmans et al. 2004; Qi et al. 2013).
There are numerous features of viruses within the H7 subtype associated with human 
infection that set this subtype apart from other avian influenza viruses with pandemic 
potential. While H5 viruses have caused the greatest number of confirmed human infections 
among all avian influenza virus subtypes, with a great deal of clade-specific diversity among 
viruses associated with human infection, all cases have resulted from viruses possessing 
only the N1 neuraminidase (NA) (Abdel-Ghafar et al. 2008). Similarly, human infections 
with H6 and H9 viruses have been restricted to the N1 and N2 NA subtypes, respectively 
(Arzey et al. 2012; Peiris et al. 1999; Yuan et al. 2013); H10 viruses with N7 and N8 
subtypes have both been detected in humans (Arzey et al. 2012; WHO 2013). In contrast, 
human disease has resulted from H7 viruses possessing four NA subtypes, indicating a 
greater compatibility of the H7 hemagglutinin (HA) with several different NA configurations 
and suggesting that there is not a clear association of NA subtypes with virulent H7 viruses 
(Fig. 1) (Belser et al. 2009a). Furthermore, while human infection with H5, H6, and H9 
viruses has been limited to Eurasian lineage strains, among all avian-origin viruses H7 
viruses represent the subtype with the greatest number of documented human infections 
from both Eurasian and North American lineages. The diversity of these H7 avian influenza 
viruses resulting in human disease, encompassing both highly pathogenic (HPAI) and LPAI 
viruses and with select strains possessing atypical molecular determinants of virulence, also 
sets this virus subtype apart from other avian subtypes with pandemic potential. These 
features underscore the difficulty of studying the subtype as a whole, frequently requiring 
the inclusion of several virus isolates when establishing experimental designs to eliminate 
strain-specific differences inherent among this virus subtype.
Due to the pronounced heterogeneity among H7 subtype viruses associated with human 
infection, there is an urgent public health need to develop mammalian models for the study 
of pathogenicity and transmissibility, and to assess lineage-specific and strain-specific 
diversity of viruses within this subtype. Furthermore, the frequent detection of conjunctivitis 
with occasional and generally mild respiratory illness caused by H7 viruses in humans 
necessitates the development of models which reflect the multiple exposure routes exploited 
by this virus subtype. In this review, we discuss the pathogenicity and transmissibility of 
Eurasian and North American lineage H7 subtype viruses associated with human exposure 
and infection in the two most frequently employed mammalian models in this research, the 
mouse and ferret. Mice are well suited to study the pathogenesis of avian influenza viruses, 
as these viruses typically replicate well in the murine respiratory tract, unlike human viruses 
that generally require prior host adaptation. Ferrets support the replication of both human 
and avian strains, and represent the best small animal model for the coincident study of 
influenza virus pathogenesis and transmissibility. The development of these models has 
greatly enabled the investigation of the molecular determinants of virulence associated with 
HPAI and LPAI Eurasian and North American lineage H7 viruses, and provided the ability 
to assess existing and novel vaccine and antiviral approaches to mitigate human infection 
and illness from this virus subtype (Table 1).
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2 Eurasian Lineage Viruses
2.1 Historical H7 Viruses
The first descriptions of fowl plague, now recognized as highly pathogenic avian influenza, 
date to the late nineteenth century. The first documented isolation of an influenza virus was 
of the H7N7 subtype in 1902 from an outbreak of fowl plague virus (FPV) in Italy, predating 
the first isolation of a human influenza virus by thirty years (Horimoto and Kawaoka 2001). 
Documented human infection with a fowl plague virus dates to 1959, with additional human 
cases infrequently detected, typically following laboratory or occupational exposure (Belser 
et al. 2009a). While belonging to a separate phylogenetic clade, these historical H7 influenza 
viruses exhibit closest sequence similarity to the current Eurasian lineage (Bulach et al. 
2010). Eurasian lineage H7 viruses isolated throughout the 20th century have exhibited great 
strain-specific diversity; most viruses examined have been found to infect mice without prior 
adaptation, with select H7N1 and H7N3 viruses causing lethal disease in this species 
(Joseph et al. 2007). Interestingly, many of these viruses elicit broadly cross-reactive 
antibodies to contemporary Eurasian and North American viruses (Joseph et al. 2007).
Equine influenza viruses of the H7N7 subtype were first isolated in 1956 (Timoney 1996). 
Despite only causing mild respiratory symptoms in horses, equine H7N7 influenza viruses 
were found to be lethal in mice without prior adaptation, with the capacity for enhanced 
neurovirulence in this species following murine adaptation (Christensen et al. 2000; 
Kawaoka 1991; Shinya et al. 2005, 2007). This is likely due to the presence of a multibasic 
amino acid HA0 cleavage site among these viruses, a molecular determinant of virulence 
frequently detected in viruses that exhibit a high pathogenicity phenotype in mice. While 
they have not been isolated from horses since 1978, serologic evidence supporting the 
continued circulation of equine H7N7 viruses in horses has been reported (Abd El-Rahim 
and Hussein 2004; Mancini et al. 2012; Timoney 1996; Webster 1993).
2.2 H7N7 Viruses
The first well-documented case of direct transmission of an H7 subtype avian influenza 
virus from an avian to a human host occurred in 1996 in England (Kurtz et al. 1996). The 
causative strain, a LPAI H7N7 virus, possessed a close phylogenetic relationship with H7 
viruses isolated from poultry in the area (Banks et al. 1998). Transmission likely occurred 
following ocular exposure to infected ducks, and the exposed woman developed 
conjunctivitis; no subsequent human cases were detected (Belser et al. 2009a). The virus 
isolated from the human case replicated in the respiratory tract of inoculated mice without 
prior adaptation but did not cause severe disease in this model (Belser et al. 2009b). An 
outbreak of HPAI H7N7 virus in Italy resulting in three confirmed cases of human 
conjunctivitis represents the most recent detection of this virus (ProMED-mail 2013); 
research investigating the virulence of these isolates in mammalian models is ongoing.
In 2003, an outbreak of HPAI H7N7 virus in the Netherlands necessitated the culling of >30 
million birds, and resulted in 89 virologically confirmed human cases, representing the 
largest instance of HPAI H7 subtype infection in humans to date (Fouchier et al. 2004; 
Koopmans et al. 2004). The majority of human infections presented as conjunctivitis, though 
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respiratory symptoms were occasionally detected; there was one fatality, due to acute 
respiratory distress syndrome (Fouchier et al. 2004). Two molecular features of viruses 
isolated from this outbreak were similar to those identified in HPAI H5N1 viruses: the 
presence of a multibasic amino acid HA cleavage site and, in the virus isolated from the fatal 
case (A/Netherlands/219/03, NL/219), the presence of a lysine at position 627 in PB2 
(Fouchier et al. 2004). With the exception of E627K, many of the known molecular markers 
of virulence and human adaptation present among human isolates were detected in poultry 
isolates before potential avian-to-human transmission events (Jonges et al. 2011), 
underscoring the need for early intervention during outbreaks of influenza virus in poultry.
Viruses isolated from the 2003 Netherlands outbreak were found to be highly infectious in 
mice following intranasal inoculation, replicating efficiently throughout the murine 
respiratory tract and demonstrating the capacity for systemic spread to extrapulmonary 
tissues, including the brain (Belser et al. 2007; de Wit et al. 2005; Joseph et al. 2007). Most 
viruses from this outbreak caused substantial morbidity in mice before eventual recovery, 
with select viruses (including the fatal case isolate NL/219) possessing a lethal dose 
comparable to H5N1 viruses which exhibit a high pathogenicity phenotype in this species 
(Belser et al. 2007; de Wit et al. 2005; Joseph et al. 2007). HPAI H7N7 viruses from 2003 
also replicated to high titer following intranasal inoculation in ferrets, exhibiting systemic 
spread to extrapulmonary tissues and causing fever, weight loss, nasal discharge, and 
transient lymphopenia (Belser et al. 2007). Similar to mice, NL/219 virus exhibited a high 
pathogenicity phenotype in ferrets, with ferrets losing >20% of their initial body weight and 
exhibiting neurological symptoms during the course of infection, necessitating euthanasia.
Due to the high incidence of conjunctivitis among infected individuals, several studies were 
conducted to assess the ocular tropism of HPAI H7N7 viruses in mammalian models. 
Underscoring the ability of H7 viruses to both use the eye as a site of virus replication and as 
a portal of entry to establish a productive respiratory infection, virus was detected in ocular 
and respiratory tissues of both mice and ferrets when inoculated by the ocular route with 
isolates from the Netherlands outbreak (Belser et al. 2009c, 2012a). Furthermore, NL/219 
virus maintained a lethal phenotype in mice (but not ferrets) following ocular inoculation. 
Notably, HPAI H7N7 viruses were detected in ferret ocular tissue following traditional 
intranasal inoculation, indicating that influenza viruses can spread from nasal to ocular 
tissues more readily than previously considered (Belser et al. 2012a, 2013c).
Limited human-to-human transmission was reported during the Netherlands outbreak 
(Koopmans et al. 2004), raising the need to model transmissibility of HPAI H7N7 viruses. 
NL/219 virus was not capable of transmission to naïve contacts in the ferret model, similar 
to HPAI H5N1 viruses. However, a virus isolated from a conjunctivitis case (A/Netherlands/
230/03, NL/230) transmitted in a ferret direct contact model following either intranasal or 
ocular inoculation of ferrets, though airborne transmission was not detected (Belser et al. 
2008, 2012a).
2.3 H7N1, H7N2, and H7N3 Viruses
H7N1, H7N2, and H7N3 influenza viruses have been responsible for frequent poultry 
outbreaks in Europe and Asia in recent years (Alexander 2007; Brown 2010). While reduced 
Belser and Tumpey Page 4
Curr Top Microbiol Immunol. Author manuscript; available in PMC 2018 February 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
in scope compared with the Netherlands outbreak in 2003, these epornitics have resulted in 
large culling operations leading to human occupational exposure and occasional infection 
(Fig. 1) (2007; Nguyen-Van-Tam et al. 2006; Puzelli et al. 2005). Suspected and confirmed 
human cases have been reported following several of these outbreaks, with disease ranging 
from mild to severe (Dudley 2008; Eames et al. 2010; Nguyen-Van-Tam et al. 2006; Puzelli 
et al. 2005).
Numerous poultry outbreaks of LPAI (H7N1, H7N3) and HPAI (H7N1) viruses have been 
reported in Italy since 1999. Viruses isolated from the 1999–2000 HPAI H7N1 outbreak in 
Italy generally demonstrated similar pathogenicity in mice as HPAI H7N7 viruses from the 
Netherlands, with frequent detection of extrapulmonary spread and lethality reported among 
select isolates (Rigoni et al. 2007; Whiteley et al. 2007). However, while systemic spread of 
virus was detected in ferrets (albeit later in infection, with virus detected day 6 p.i. and not 
day 3 p.i. as compared with HPAI H7N7 viruses), the lethal phenotype observed with 
selected HPAI H7N1 viruses does not appear to be maintained in this model (Cox et al. 
2009; Whiteley et al. 2007). Virus was not isolated from any exposed individuals from these 
outbreaks, though a percentage (<4 %) of tested poultry workers exhibited seroconversion to 
H7 virus, albeit at very low titers (Di Trani et al. 2012; Puzelli et al. 2005).
The first introduction of LPAI H7N3 virus to Pakistan occurred in 1995, with viruses 
acquiring a HPAI phenotype within a year of circulation in chickens (Abbas et al. 2010). 
Over the following decade, H7N3 viruses caused sporadic outbreaks in geographically 
distinct regions of the country, suggesting a virus reservoir in poultry. HPAI H7N3 viruses 
isolated from Pakistan between 1995 and 2002 replicated efficiently in the lungs of 
inoculated mice, but did not spread to extrapulmonary tissues; lethality in this model was 
observed among the most recently isolated strains (Aamir et al. 2009). Similar to HPAI 
H7N1 viruses, ferrets inoculated by the intranasal or ocular route with an HPAI H7N3 virus 
associated with lethality in mice exhibited moderate signs of illness but did not succumb to 
infection. It is important to note that while the majority of mammalian pathotyping of H7 
viruses occurs with strains associated with human infection or large poultry outbreaks, 
viruses that are detected during routine surveillance have been shown to replicate efficiently 
in mammalian models. As an example, a LPAI H7N2 virus from northern China isolated in 
2002 was found to replicate efficiently in both pulmonary and extrapulmonary tissues in 
mice (Li et al. 2006), underscoring the ability of H7 avian influenza viruses to replicate in 
mammals without prior adaptation and emphasizing the continuous need for surveillance of 
galliform poultry for strains which could possess pandemic potential.
Conjunctivitis is a frequent symptom among suspected and virologically confirmed cases of 
H7N1, H7N2, and H7N3 virus infection (Dudley 2008; Puzelli et al. 2005). Similar to HPAI 
H7N7 viruses, virus was recovered from eye swabs of intranasally (HPAI H7N1) or ocularly 
(HPAI H7N3) inoculated ferrets, though the detection of other avian and human influenza 
viruses recovered from ferret ocular samples indicates that this ability is not specific to H7 
subtype viruses (Aamir et al. 2009; Belser et al. 2012a; Cox et al. 2009). While mice 
inoculated by the ocular route with influenza viruses typically do not display macroscopic 
ocular signs of disease, ocular symptoms were nonetheless detected among HPAI H7N1 and 
H7N3 viruses following intranasal inoculation in mice (Aamir et al. 2009; Cox et al. 2009; 
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Belser et al. 2009c). These studies further support the ability of Eurasian lineage H7 viruses 
to employ the ocular system during in vivo mammalian infection.
Unfortunately, mammalian pathotyping of avian H7 subtype viruses associated with all 
human outbreaks has not been performed, and the transmissibility of these viruses has not 
been well examined in mammalian models. HPAI H7N1 viruses were reported to transmit in 
a direct contact mouse model (Rigoni et al. 2010), though there is a paucity of data 
establishing mice as a reliable transmission model for influenza viruses. While human-to-
human transmission has not been confirmed among the outbreaks discussed here, contact 
tracing of suspected cases from an outbreak of LPAI H7N2 virus in Wales indicates that 
limited independent chains of person-to-person transmission cannot be ruled out (Eames et 
al. 2010). Future studies are needed to better identify the capacity of these viruses to 
transmit between mammals, as studied previously using viruses from the Netherlands 
outbreak.
2.4 LPAI H7N9 Viruses
Eurasian lineage LPAI H7N9 viruses had been previously detected during surveillance 
activities, but not until 2013 were these viruses associated with human infection (Gerloff et 
al. 2013; Gonzalez-Reiche et al. 2012; Perez-Ramirez et al. 2010). Human infections, 
totaling over 440 confirmed cases with over 160 fatalities, have been characterized by severe 
pulmonary disease and acute respiratory distress syndrome (Gao et al. 2013b). The majority 
of human infections have resulted from exposure to infected poultry, though evidence for 
limited human-to-human transmission has been reported (Li et al. 2013; Qi et al. 2013). 
Interestingly, the older median age among H7N9 cases compared with H5N1 cases, and the 
relatively few reports of mild cases among H7N9-infected individuals, indicates potential 
differences in susceptibility to severe illness for these avian viruses (Cowling et al. 2013).
The unexpected severe disease following human infection with a LPAI virus warranted swift 
assessment of the virulence of H7N9 viruses in mammalian models. Mice inoculated by the 
intranasal route with the first human isolates A/Anhui/1/13 (Anhui/1) and A/Shanghai/1/13 
generally showed severe morbidity and comparable lethality as HPAI H5N1 and H7N7 
viruses, though strain-specific differences in virulence have been detected and not all human 
isolates possess a lethal phenotype in this model (Baranovich et al. 2013; Belser et al. 
2013b; Mok et al. 2013; Watanabe et al. 2013; Zhang et al. 2013). While extrapulmonary 
spread of virus is frequently associated with a lethal outcome in infected mice, viral titers in 
the brain were only sporadically reported following H7N9 infection (Belser et al. 2013b; 
Zhang et al. 2013). In contrast, avian isolates tested from this outbreak (which lack a lysine 
at position 627 in PB2) were not highly pathogenic in mice (Zhang et al. 2013). This is in 
accord with other genetically related LPAI H7N9 viruses isolated in prior years from avian 
species which possess comparable infectivity and replicative ability in murine respiratory 
tract tissues but did not maintain the high virulence observed with human isolates in this 
species (Belser et al. 2013b; Mok et al. 2013; Watanabe et al. 2013).
Ferrets were used extensively to characterize the pathogenicity of LPAI H7N9 viruses 
isolated from humans. Intranasally inoculated ferrets exhibited modest signs of disease, 
including weight loss, fever, sneezing and lethargy, but generally did not maintain the lethal 
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phenotype observed in the mouse model (Belser et al. 2013b; Watanabe et al. 2013; Zhu et 
al. 2013). H7N9 viruses replicated efficiently throughout the ferret respiratory tract; virus 
was frequently but not uniformly detected in the lungs, with moderate inflammation and 
inflammatory infiltrates detected in bronchioles and alveoli (Belser et al. 2013b; Watanabe et 
al. 2013; Zhu et al. 2013). Lymphopenia and leukopenia, often detected among severe 
human cases, were also observed in infected ferrets, though levels of circulating white blood 
cells generally returned to pre-infection levels following the acute phase of infection (Belser 
et al. 2013b; Gao et al. 2013a; Xu et al. 2013b). While nonhuman primates are not typically 
utilized for the study of H7 influenza viruses, cynomolgus macaques inoculated with 
Anhui/1 virus in one study exhibited generally comparable levels of pathogenicity as 
observed in ferrets (Watanabe et al. 2013). Taken together, these studies found that LPAI 
H7N9 viruses exhibit similar disease in the ferret as HPAI H7N7 viruses, but cause a less 
severe infection compared to highly virulent HPAI H5N1 viruses (Maines et al. 2005).
The association of LPAI H7N9 viruses with severe respiratory disease in humans is in 
disaccord with the mild ocular and/or respiratory disease most typically observed following 
infection with H7 viruses (Belser et al. 2009a). However, varying the inoculation route was 
found to modulate H7N9 virulence, as intratracheal inoculation of ferrets with Anhui/1 virus 
lead to heightened morbidity and mortality compared to traditional intranasal inoculation 
(Kreijtz et al. 2013). While LPAI H7N9 viruses have not exhibited an ocular tropism in 
humans, swollen eyes were reported at the onset of mild respiratory illness in one H7N9 
virus-positive poultry worker wearing respiratory but not ocular protection during the time 
of occupational exposure (Lv et al. 2013), suggesting that the virus may have employed the 
ocular route to cause human disease. In support of this, virus was detected in the respiratory 
tract of mice inoculated by the ocular route, as well as in the eye washes of ferrets inoculated 
by the intranasal route (Belser et al. 2013b). Collectively these results indicate that, similar 
to other influenza viruses, H7N9 virus can utilize multiple exposure routes to mount a 
productive infection in mammals, with severity of disease influenced by the route of 
infection.
The presence among several H7N9 isolates of amino acid changes known to increase 
binding to α2-6 linked sialic acids, notably Q226L in the HA protein, suggested that these 
viruses were capable of enhanced transmissibility compared to other avian-origin viruses 
(Gao et al. 2013b). H7N9 isolates were found to transmit efficiently between either ferrets or 
guinea pigs when placed in direct contact, a capacity not generally present among avian 
influenza viruses (Belser et al. 2013b; Gabbard et al. 2013; Maines et al. 2006; Zhu et al. 
2013). However, while the incidence of H7N9 virus transmission between ferrets in the 
absence of direct or indirect contact (i.e. respiratory droplet or airborne transmission) was 
greater than that observed among H7N9 viruses isolated from avian species, transmission 
was overall less efficient than seasonal or pandemic influenza viruses in this model, with 
delayed kinetics of virus spread to contact ferrets when transmission did occur (Belser et al. 
2013b; Maines et al. 2006, 2009; Richard et al. 2013; Watanabe et al. 2013; Xu et al. 2013a; 
Zhang et al. 2013; Zhu et al. 2013). While selected studies have observed efficient 
transmission of H7N9 viruses by respiratory droplets, serial passage of H7N9 virus in ferrets 
did not enhance virus transmissibility, further indicating that, despite the efficient 
transmissibility detected in a direct contact model, these viruses are not yet capable of 
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sustained airborne mammalian transmission and would require additional mammalian 
adaptation to achieve this property (Richard et al. 2013; Zhang et al. 2013).
3 North American Lineage Viruses
3.1 Historical H7 Viruses
North American lineage H7 viruses, similar to those within the Eurasian lineage, have been 
detected numerous times throughout the twentieth century, most frequently from avian 
species. The majority of these viruses examined have been found to infect mice without 
prior adaptation, though rarely have they been associated with lethal disease in this species 
following intranasal inoculation (Goff et al. 2013; Joseph et al. 2007). In 1979–1980, an 
H7N7 virus caused the death of ~500 seals on the New England coast, subsequently 
resulting in five cases of conjunctivitis among laboratory workers with occupational 
exposure to the virus (one virologically confirmed, four suspect cases) (Lang et al. 1981; 
Webster et al. 1981). This virus only caused mild respiratory disease in mice, and did not 
infect experimentally inoculated ferrets or rats (Scheiblauer et al. 1995). However, 
mammalian passage of a laboratory variant of this virus was capable of causing lethal 
disease in mice and ferrets, indicating that the H7N7 virus could acquire neurotropic and 
pathogenic properties following host adaptation.
3.2 LPAI H7 Viruses in the United States
LPAI H7N2 virus was first isolated from northeastern United States live bird markets (LBM) 
in 1994, and persisted for over a decade before the virus was eradicated from those markets 
in 2006 (Senne 2010; Senne et al. 2003). During this time, the largest outbreak of LPAI in 
the United States occurred in 2002 in Virginia and the surrounding area, due to an H7N2 
virus with high genetic sequence identity to the LBM circulating strains (Senne 2007). 
These viruses were associated with one confirmed case of human infection (A/New York/
107/03, NY/107) and one suspected case (among 80 tested poultry workers) with 
occupational exposure who seroconverted to H7N2 virus during the Virginia outbreak (CDC 
2004; Ostrowsky et al. 2012). Despite the elimination of H7N2 viruses from the northeastern 
United States LBM system, H7 subtype viruses continue to circulate across the United 
States, as H7N3, H7N7, and H7N9 subtype viruses have been isolated from wild birds and 
galliform poultry over the past decade (Pasick et al. 2012; Senne 2007, 2010). While these 
viruses have not caused any confirmed human cases, seroprevalence studies have reported 
statistically significant elevated titers against H7 influenza virus in veterinarians compared 
to healthy control subjects, suggesting that occupational exposure may be occurring (Myers 
et al. 2007).
LPAI H7 viruses from North America have typically not caused severe disease in 
experimentally inoculated mammalian models. In mice, virus replicates efficiently in both 
the nose and lung following intranasal inoculation, with extrapulmonary spread generally 
not observed (Belser et al. 2007, 2013a; Joseph et al. 2007). However, LPAI H7 viruses are 
highly infectious in this model, and morbidity can range from mild to moderate depending 
on the strain used to infect. Similar results are detected in the ferret model, though viral 
titers are generally lower in the lung compared with the nasal turbinates and trachea (Belser 
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et al. 2007, 2008, 2013a). Ferret morbidity is generally mild and transient, with few 
lymphohematopoietic perturbations and an absence of extrapulmonary virus spread.
Similar to Eurasian lineage H7 viruses, many LPAI H7 viruses from the North American 
lineage can employ the mammalian eye as a site of primary virus replication as well as a 
portal of entry to spread to the respiratory tract (Belser et al. 2009c Belser et al. 2012, 
2013a). Ocular inoculation of mice with LPAI H7N3 and H7N9 viruses resulted in 
detectable virus titers in both eye and respiratory tract tissues in the absence of significant 
morbidity, as did ferrets inoculated by the ocular route with the LPAI H7N2 virus NY/107 
(Belser et al. 2012a, 2013a). These findings indicate that avian isolates not associated with 
human disease are still capable of using the eye as a portal of entry to cause a productive 
mammalian infection.
Unlike the majority of Eurasian lineage viruses (with the exception of LPAI H7N9 viruses), 
selected contemporary North American viruses possess the ability to bind both α2-3 and 
α2-6 linked sialic acids, as will be discussed in more detail in the subsequent section. As a 
binding preference for α2-6 linked sialic acids is a feature of human and pandemic influenza 
viruses, continued evaluation of the transmissibility of North American H7 viruses has 
become essential to monitor the true pandemic potential of these viruses. Notably, several 
LPAI H7N2 viruses have been found capable of transmission to naïve contacts in the 
presence of direct contact. NY/107 virus was found to transmit efficiently in a direct contact 
model following either intranasal or ocular inoculation of ferrets (Belser et al. 2008, 2012a). 
A chicken LPAI H7N2 virus from 2003, but not a turkey isolate from 2002, was also capable 
of limited transmission in a direct contact model, despite both viruses exhibiting a similar 
receptor-binding profile as NY/107 virus, indicating that receptor binding preference alone 
does not confer a transmissible phenotype (Belser et al. 2008). However, no wild-type LPAI 
H7 North American strains have been found capable of transmission between ferrets by the 
airborne route to date.
3.3 HPAI H7N3 Viruses
HPAI H7N3 viruses have caused numerous poultry outbreaks in both North and South 
America (Lopez-Martinez et al. 2013; Senne 2007, 2010). Unlike Eurasian HPAI H5N1 and 
H7N7 viruses which typically possess traditional multibasic amino acid HA cleavage sites, 
these HPAI H7N3 viruses all appear to have arisen from LPAI precursor viruses by 
nonhomologous recombination between the HA and other viral genes or host cell genetic 
sequences (Berhane et al. 2009; Maurer-Stroh et al. 2013; Pasick et al. 2005; Suarez et al. 
2004). To date, H7 viruses are the only known subtype to use this mechanism as a way to 
acquire a virulent phenotype. Several of these epornitics have resulted in human infection, 
underscoring the need to study the virulence of these viruses which pose a threat to both 
avian and human health and to elucidate why H7 subtype viruses are most susceptible to this 
form of recombination. Unfortunately, viruses from these unique outbreaks have been 
infrequently studied in mammalian models, limiting our understanding of how the H7 HA 
cleavage site influences viral pathogenicity.
An outbreak of LPAI H7N3 virus occurred in Chile in May 2002, representing the first 
isolation of H7 influenza virus in poultry or wild birds in the continent of South America 
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(Suarez et al. 2004). Recombination between the HA and nucleoprotein genes of the LPAI 
virus resulted in the generation of a HPAI virus within a month; no human cases were 
reported during the 7 months of eradication efforts (Max et al. 2007). Despite exhibiting 
differential infectivity and virulence in poultry, both HPAI and LPAI viruses from this 
outbreak replicated efficiently in the lungs of mice in the absence of substantial morbidity or 
mortality (Belser et al. 2013a; Jones and Swayne 2004; Joseph et al. 2007).
In 2004, an H7N3 virus detected in British Columbia, Canada acquired a high pathogenicity 
phenotype in chickens following a nonhomologous recombination event between the HA 
and matrix genes (Hirst et al. 2004). This outbreak necessitated the culling of over 19 
million birds, and resulted in 55 suspected and two virologically confirmed human 
infections (Tweed et al. 2004). While both human cases presented with conjunctivitis and 
influenza-like illness following direct conjunctival contact with poultry, virus isolated from 
one human case was found to be LPAI whereas the other human isolate (A/Canada/504/04, 
Can/504) was found to be HPAI (Hirst et al. 2004; Tweed et al. 2004); one additional basic 
amino acid was present in the cleavage region of the HPAI virus compared with the LPAI 
strain (Hirst et al. 2004). Similar to the H7N3 viruses from Chile, both HPAI and LPAI 
H7N3 viruses associated with human infection, as well as a closely related LPAI chicken 
isolate from this outbreak and a mallard LPAI H7N3 virus isolated in 2001, replicated 
efficiently in the lungs of mice but did not spread to extrapulmonary tissues following 
intranasal inoculation (Belser et al. 2007; Joseph et al. 2008; Song et al. 2009). However, a 
HPAI chicken isolate from this outbreak was capable of lethality and extrapulmonary spread 
to the brain following intranasal murine inoculation, indicating strain-specific differences in 
virulence among these HPAI H7N3 viruses (Belser et al. 2008; Joseph et al. 2007). Both 
HPAI and LPAI chicken isolates from the 2004 H7N3 outbreak replicated efficiently in 
ferret upper and lower respiratory tract tissues (Joseph et al. 2008). Unlike mice, ferrets 
inoculated by the intranasal route with Can/504 virus exhibited substantial weight loss 
before recovery, indicating species-specific differences in mammalian virulence among 
HPAI H7N3 viruses from this outbreak. A subsequent outbreak of HPAI H7N3 in 
Saskatchewan, Canada in 2007 also emerged from a nonhomologous recombination event 
with a genetic sequence of eukaryotic origin, but did not result in confirmed human infection 
(Pasick et al. 2010); the causative virus has not been extensively studied in mammalian 
models.
The most recent outbreak of HPAI H7N3 virus occurred in Jalisco, Mexico in 2012, 
resulting in the culling of over 22 million birds and the detection of two confirmed human 
cases among poultry workers, both presenting with conjunctivitis (Kreijtz et al. 2013; 
Lopez-Martinez et al. 2013). Similar to other HPAI H7N3 viruses from North America, 
isolates from this outbreak also possess an extended HA cleavage site, with the insertion 
likely acquired from host 28S ribosomal RNA (Lopez-Martinez et al. 2013; Maurer-Stroh et 
al. 2013). Mice inoculated with virus isolated from a human conjunctivitis case (A/Mexico/
InDRE7218/12, (Mex/7218)) exhibited greater morbidity and mortality compared with 
previously examined North American HPAI H7N3 viruses, causing severe morbidity and 
lethal disease in mice intranasally inoculated with high (106 EID50) doses of virus (Belser et 
al. 2013a). Similar to mice, Mex/7218 virus replicated to high titer throughout the ferret 
respiratory tract following intranasal inoculation, including the lung, but did not spread 
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systemically to multiple organs. However, extrapulmonary spread of virus was detected in 
the brain and gastrointestinal tract of infected ferrets, although all ferrets survived viral 
challenge (Belser et al. 2013a).
Conjunctivitis was documented among all human infections with North American H7N3 
viruses, underscoring a need to examine the pathogenicity of these viruses following ocular 
exposure. Mice inoculated by the ocular route with HPAI H7N3 human isolates from 
Canada and Mexico did not exhibit significant morbidity or mortality, but did possess 
detectable virus in both ocular and respiratory tract tissues post-inoculation (Belser et al. 
2009c, 2013a). Similarly, ferrets inoculated by the ocular route with Can/504 virus became 
productively infected in the absence of substantial morbidity, with virus detected in samples 
collected from both the respiratory tract and eye (Belser et al. 2012a).
Just as North American lineage LPAI H7N2 viruses have exhibited limited transmissibility 
in a direct contact ferret model, LPAI and HPAI H7N3 viruses from several of these 
outbreaks have also demonstrated this property. Low levels of the HPAI H7N3 virus 
Can/504 isolated from a human conjunctivitis case, were transmitted to ferrets in a direct 
contact model (Belser et al. 2008). The HPAI H7N3 virus Mex/7218, also isolated from a 
conjunctivitis case, efficiently transmitted to naïve ferrets in a direct contact model, though a 
genetically related North American LPAI H7N9 virus did not (Belser et al. 2013a). 
Strikingly, transmission in the presence of direct contact was also reported with a mallard 
LPAI H7N3 virus in the absence of prior host adaptation, underscoring the need for 
continued surveillance and evaluation of H7 viruses from wild birds (Song et al. 2009). 
However, similar to other North American H7 viruses, airborne transmission of H7N3 
viruses has not been reported to date.
4 Molecular and Host Determinants of Pathogenicity and Transmissibility
4.1 Molecular Correlates of Pathogenicity
The majority of research studies investigating molecular determinants associated with 
mammalian virulence of avian influenza viruses have been conducted with H5 and not H7 
subtype viruses. However, it appears that many features associated with H5N1 virulence are 
maintained in H7 subtype viruses, especially with regard to the virus HA. Similar to results 
obtained using H5N1 strains, reassortant viruses bearing surface glycoproteins derived from 
a virulent H7 virus on the backbone of a nonlethal H7 virus exhibit moderately enhanced 
virulence without increases in lethality in mammalian species (Munster et al. 2007; Salomon 
et al. 2006). The introduction of glycosylation sites proximal to the receptor binding pocket 
of the HA has been shown to facilitate adaptation of H7 and H5 viruses from wild birds to 
poultry and modulate virulence in mammalian hosts (Banks and Plowright 2003; Belser and 
Tumpey 2013; de Wit et al. 2010). Building upon prior studies conducted with H5N1 viruses 
has thus enabled greater precision in the identification of molecular markers of H7 subtype 
virulence.
Previous studies on H5N1 mammalian virulence have indicated that while a multibasic 
amino acid HA cleavage site is necessary (Hatta et al. 2001; Horimoto and Kawaoka 1994; 
Suguitan et al. 2012), this molecular feature alone is not sufficient for a virulent phenotype 
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in mammals (Maines et al. 2005). In this vein, studies with H7 viruses have demonstrated 
that the presence of a multibasic amino acid cleavage site does not necessarily confer a 
virulent phenotype in either avian or mammalian species (Belser et al. 2007; Senne et al. 
1996). While the composition of HA cleavage sites among Eurasian lineage LPAI and HPAI 
H7 viruses generally resemble that of H5N1 viruses, there is a greater diversity among North 
American H7 viruses. Insertion of additional basic amino acids at the cleavage site of a LPAI 
H7N2 virus, but not mutation of residues already present at the cleavage site, resulted in 
viruses which were highly pathogenic in chickens, demonstrating the capacity of an H7 
virus to acquire a pathogenic phenotype, in contrast to H5 viruses which can acquire a 
virulent phenotype by either mutation or insertion (Lee et al. 2006). Molecular modeling of 
the insertional event resulting in a HPAI H7N3 virus isolated from Canada in 2004 revealed 
an enlarged loop formation resulting in greater accessibility of the HA cleavage site, likely 
leading to increased cleavage by furin-like proteases resulting in enhanced pathogenicity 
(Hirst et al. 2004). Future study is needed to better understand the contribution and 
mechanism of HA cleavage site insertions as they pertain to mammalian pathogenesis, 
especially among North American lineage viruses.
The presence of a lysine at position 627 in PB2 has long been identified as a critical factor of 
mammalian adaptation and virulence among influenza viruses, including HPAI H5N1 
viruses (Hatta et al. 2001; Subbarao et al. 1993). As mentioned in preceding sections, several 
studies have demonstrated a similar role for this position among H7 subtype viruses. An 
E627K substitution in a HPAI H7N7 virus isolated from the Netherlands was identified as a 
major determinant of mammalian pathogenicity, with viruses bearing this mutation 
exhibiting increased viral load, extrapulmonary spread to the brain, and heightened mortality 
in mice; this enhanced virulence was absent in mice inoculated with virus bearing the 
reciprocal K627E mutation (de Jong et al. 2013; Munster et al. 2007). Similarly, the 
presence of a lysine at this position in LPAI H7N9 human isolates and a mouse-adapted 
H7N7 equine virus resulted in increased PB2 polymerase activity, viral loads, and disease 
severity in mice (Mok et al. 2014; Shinya et al. 2007; Zhang et al. 2013, 2014). Enhanced 
virulence of HPAI H7N7 viruses bearing E627K was also observed in ferrets compared with 
virus bearing glutamic acid at this position (de Jong et al. 2013). However, H7N9 viruses 
bearing either a glutamic acid or lysine at position 627 exhibited comparable transmissibility 
in the ferret model, indicating E627K does not solely confer an enhanced transmissibility 
phenotype (Zhang et al. 2013). These studies are supported by in vitro assays in human cell 
types revealing that the E627K mutation confers enhanced replicative ability and polymerase 
activity compared with K627E (de Wit et al. 2010). While the presence of E627K yields 
heightened virulence in mice, it should be noted that select viruses lacking this mutation are 
still capable of extrapulmonary spread and murine lethality (Aamir et al. 2009; Rigoni et al. 
2007), demonstrating the polygenic nature of mammalian virulence and underscoring that 
PB2 position 627 is only one of several molecular determinants that contribute to 
mammalian pathogenicity. In support of this, additional mutations in the H7 viral 
polymerase independent of position 627 have been demonstrated to modulate virulence in a 
mouse model (Gabriel et al. 2005, 2007; Yamayoshi et al. 2013). Disruption of protein–
protein binding between PA and PB1 was also shown to attenuate murine virulence of an 
H7N7 virus (Manz et al. 2011).
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The influenza non-structural (NS1) protein possesses several varied functions which 
contribute to block type-1 interferon-mediated host antiviral responses (Garcia-Sastre 2001). 
A mouse-adapted H7N7 virus with a complete deletion of the NS1 gene was nonpathogenic 
in wild-type mice, suggesting that enhanced synthesis of IFN in infected mouse lungs led to 
virus attenuation in this species (Kochs et al. 2007). Comparison of NS1 proteins encoded 
by different subtypes in vitro revealed that an H7 NS1 induced lower levels of 
proinflammatory cytokines, chemokines, and levels of apoptosis compared to an H5 NS1 
(Lam et al. 2011); this is in agreement with in vivo studies which detect proinflammatory 
cytokines and chemokines in respiratory tract tissues of mice and ferrets inoculated by the 
intranasal route with H7 subtype viruses, albeit at lower levels than virulent HPAI H5N1 
viruses (Belser et al. 2007, 2013c). However, a recombinant H7N7 virus bearing the NS 
gene from a fatal human case did not enhance the virulence of an H7N7 virus isolated from 
a conjunctivitis case, indicating that this gene does not represent a major determinant of 
virulence among H7 strains (Munster et al. 2007).
Dysregulation of innate host immune responses and other host factors following H5N1 virus 
infection in mammals has been shown to contribute to the high pathogenicity phenotype of 
this virus subtype (Belser and Tumpey 2013), but there are only limited studies conducted in 
the context of mammalian H7 virus infection. H7N7 virus infection of different inbred 
laboratory mouse strains resulted in divergent survival outcomes, demonstrating a role for 
the genetic background of the host in H7 mammalian virulence (Srivastava et al. 2009). The 
interferon-induced resistance factor Mx1 has been shown to contribute to interferon-
mediated protection against both avian and human influenza viruses, including the H7 
subtype, as viruses which cause lethal disease in standard laboratory mouse strains (which 
lack a functional Mx1 gene) do not maintain a lethal phenotype in mice carrying a wild-type 
functional Mx1 gene (Koerner et al. 2007; Tumpey et al. 2007). However, Mx1-positive 
mice lacking functional toll-like receptor (TLR)-7 signaling or which were depleted of 
plasmacytoid dendritic cells exhibit a decrease in resistance to a mouse-adapted HPAI H7N7 
virus isolate of seal origin (SC35M), indicating TLR7-mediated detection of H7 virus via 
plasmacytoid dendritic cells represents a source of interferon which confers antiviral 
protection in the host (Kaminski et al. 2012). Lymphopenia has been reported following H7 
virus infection in mice and ferrets (Belser et al. 2007); studies using SC35M virus found that 
the high polymerase activity of this strain was responsible for the severe lymphocyte 
depletion and impaired immune response observed in SC35M virus-infected mice but not in 
the non-mouse-adapted counterpart (Gabriel et al. 2009). Collectively, these studies indicate 
that while several molecular determinants of avian influenza virulence are maintained 
between H5 and H7 viruses, there are numerous ways in which H7 subtype viruses 
differentially interact with the mammalian host.
4.2 Receptor Binding and Correlates of Transmissibility
The distribution of host cell glycoconjugates containing terminal sialic acid moities, which 
serve as the receptors for all influenza viruses, greatly contributes to the tissue tropism and 
pandemic potential of influenza viruses in humans. Avian influenza viruses, such as HPAI 
H5N1 viruses, typically exhibit preferential binding to sialic acids linked to galactose by an 
α2-3 linkage; in humans, these receptors are generally located in the lower respiratory tract. 
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In contrast, human influenza viruses preferentially bind to α2-6 linked sialic acids, which 
are present in greater abundance in the epithelia of the human upper respiratory tract 
(Matrosovich et al. 2000). Thus, the receptor binding site of the HA governs the ability of 
influenza viruses to bind sialic acids in an α2-3 linked conformation, α2-6 linked 
conformation, or both. It is generally believed that a switch in receptor-binding specificity 
from an avian-like to a human-like preference is necessary for a virus to achieve sustained 
human-to-human transmission and cause a pandemic, though an increase in α2-6 binding 
preference alone is not sufficient for efficient airborne mammalian transmission of avian 
influenza viruses (Maines et al. 2011). Analysis of contemporary Eurasian and North 
American H7 influenza viruses revealed that despite maintaining a strong preference for 
α2-3 linked sialic acids, many possess weak but detectable binding to α2-6 linked sialic 
acids (Gambaryan et al. 2012). The ferret model is most commonly used to model the 
transmissibility of human and avian influenza viruses in a laboratory setting due to similar 
lung physiology, receptor distribution, and virus attachment patterns between ferrets and 
humans (Fig. 2) (Belser et al. 2009b).
With the notable exception of LPAI H7N9 viruses, Eurasian lineage H7 viruses associated 
with human infection have generally maintained an avian-like α2-3 sialic acid receptor 
binding preference, similar to the binding preference observed with HPAI H5N1 viruses 
isolated from humans (Belser et al. 2008; Gambaryan et al. 2008, 2012; Yang et al. 2012). 
As discussed in previous sections, these Eurasian lineage H7 viruses have generally not 
transmitted well between ferrets in direct contact or respiratory droplet models. However, 
divergent patterns of transmissibility in the ferret model and attachment patterns in 
respiratory tract mammalian cells between viruses isolated from the H7N7 2003 Netherlands 
outbreak (Fig. 2) point to subtle differences in receptor binding not identified in glycan 
arrays (Belser et al. 2008; de Wit et al. 2010), highlighting the complexity between closely 
related strains and warranting further study of additional determinants of influenza virus 
receptor binding specificity.
Numerous contemporary North American H7 subtype viruses possess increased binding to 
α2-6 linked sialosides while maintaining strong binding to α2-3 linked sialosides, with 
select strains further showing reduced binding to α2-3 linked sialosides similar to human 
influenza viruses (Belser et al. 2008; Gambaryan et al. 2008; Yang et al. 2010). Viruses 
which possess increased binding to α2-6 linked sialic acids have transmitted with moderate 
to high efficiency in a ferret direct contact model, though strain-specific differences remain 
(Belser et al. 2008). Furthermore, limited transmission in a direct contact model has been 
reported among H7 viruses which maintain an avian α2-3 sialic acid binding preference 
(Song et al. 2009), indicating that additional factors contribute to the transmissibility of H7 
viruses.
HPAI H7N9 viruses isolated from China possess the highest affinity for α2-6 linked sialic 
acids among all avian viruses associated with human infection, although unlike human 
influenza viruses, maintain strong binding to α2-3 linked sialic acids (Tharakaraman et al. 
2013; Xiong et al. 2013). As mentioned earlier, this enhanced binding to human receptors is 
likely aided by the presence of a glutamine to leucine switch at position 226 of the HA 
among H7N9 viruses, a substitution previously associated with human adaptation (Gao et al. 
Belser and Tumpey Page 14
Curr Top Microbiol Immunol. Author manuscript; available in PMC 2018 February 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2013b). However, strain-specific differences in both receptor-binding preference and 
transmission efficiency have been reported among H7N9 human isolates (Belser et al. 
2013b; Watanabe et al. 2013; Zhang et al. 2013), further underscoring the polygenic nature 
of both of these properties. Decreased NA activity of the H7N9 virus compared to a human 
pandemic virus, and reduced virus replication efficiency at 33 °C compared to pandemic 
viruses, were also suggested to contribute to the reduced airborne transmissibility of this 
virus (Belser et al. 2013b; Xiong et al. 2013).
5 Use of Mammalian Models to Develop Vaccines and Antivirals Against H7 
Viruses
As discussed throughout this review, H7 influenza viruses associated with human infection 
exhibit a wide range of pathogenic and transmissible phenotypes, posing unique challenges 
in designing appropriate strategies to both reduce disease severity and prevent infection. 
Mammalian models have proven invaluable in assessing the immunogenicity and efficacy of 
novel candidate vaccines against this virus subtype. While pre-existing influenza virus-
specific CD8+ T-cell memory may provide some degree of protection against virulent 
viruses such as H7 (Christensen et al. 2000; Zhong et al. 2010), there is a clear need to 
develop effective vaccines and antivirals to protect a serologically naïve human population 
in the event of an H7 outbreak or pandemic. The poor immunogenicity observed with 
vaccine candidates against avian influenza viruses in general, and H7 viruses in particular, 
further highlights the importance of generation and testing of vaccine approaches to this 
virus subtype as well as improved means to identify appropriate correlates of protection to 
measure H7 vaccine effectiveness in mammalian species (Krammer and Cox 2013).
Numerous inactivated vaccine candidates have been generated against both Eurasian and 
North American H7 strains in pandemic preparedness efforts, generally showing promise in 
mammalian models despite variable immunogenicity. A β-propiolactone-inactivated whole 
virus vaccine against a Eurasian H7N1 virus was found to elicit humoral antibody responses 
in mice following vaccination (Hovden et al. 2009). Formalin-inactivated whole virus 
vaccines against both North American and Eurasian H7 viruses were found to be effective in 
mice following heterologous virus challenge, restricting pulmonary virus replication and 
conferring protection from lethal challenge, even in the absence of an adjuvant (Jadhao et al. 
2008; Pappas et al. 2007). However, the addition of adjuvant was found to greatly enhance 
the protection of an H7N7 classical subunit preparation in mice (de Wit et al. 2005), an 
important feature given the generally poor induction of neutralizing antibodies by this 
subtype in mammals and potential obstacles involved in eliciting broadly cross-reactive 
antibodies that can neutralize viruses from both Eurasian and North American lineages 
(Joseph et al. 2007).
Several live attenuated influenza vaccine (LAIV) candidates against H7 viruses have also 
been developed and evaluated in mammalian models for safety, immunogenicity, and 
efficacy. Both North American H7N3 and Eurasian H7N7 LAIV candidates were found to 
protect mice and ferrets from homologous and heterologous H7 viruses (Joseph et al. 2008; 
Min et al. 2010). Furthermore, sera from H7N3 and H7N7 LAIV immunized ferrets was 
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found to cross-react against Anhui/1 virus, suggesting that these vaccine candidates may 
offer some degree of protection against H7N9 strains (Talaat et al. 2009; Xu et al. 2013c); 
based on results obtained from these studies in mammalian models, both of these candidate 
vaccines have been used in clinical trials in humans (Xu et al. 2013c).
While the inactivated and LAIV candidates discussed above have relied on production 
techniques previously established for the generation of seasonal influenza virus vaccines, 
alternate approaches are also under investigation. In recent years, there has been renewed 
interest in producing egg-free inactivated influenza vaccines, especially for viruses with 
pandemic potential. H7N1 vaccines have been generated in cell culture (Cox et al. 2009), 
and those that have undergone further evaluation have been found to elicit protective 
antibody responses against homologous and heterologous viruses in both mice and ferrets 
(Legastelois et al. 2007; Whiteley et al. 2007). Non-infectious recombinant virus-like 
particles (VLPs) have been generated with both Eurasian and North American lineage H7 
HAs (either alone or co-expressed with other subtypes) and have been evaluated for their 
ability to induce serum antibody responses and confer protection against viral challenge in 
both mice and ferrets (Smith et al. 2013; Szecsi et al. 2006; Tretyakova et al. 2013). The use 
of well-characterized mammalian models for H7 virus infection has allowed for the 
evaluation of vaccine approaches against conserved HA epitopes, as mice vaccinated with 
chimeric HA constructs expressing an H3 stalk vaccine developed cross-reactive antibodies 
which protected against murine heterosubtypic challenge with H7 viruses (Krammer et al. 
2013; Margine et al. 2013). Further demonstrating the ability of antibodies raised against H7 
viruses to exhibit cross-protection, mice immunized with a recombinant Newcastle disease 
virus expressing a North American H7 HA were protected against a lethal heterologous H7 
challenge. This was also true of mice immunized with a recombinant vaccine expressing a 
Eurasian H7 HA on the surface of baculovirus subsequently challenged with a murine-
passaged homologous virus exhibiting enhanced virulence (Goff et al. 2013; Rajesh Kumar 
et al. 2013). Future study will allow for a better evaluation of these novel approaches to 
effectively elicit protective antibody and cell-mediated immune responses toward H7 
influenza viruses in humans.
In the absence of a well-matched vaccine, such as the early stages of an outbreak or 
pandemic, antivirals represent the first line of defense against influenza viruses. 
Unfortunately, the sensitivity of H7 viruses to currently available antiviral drugs has not 
been extensively examined, with a paucity of studies performed in in vivo models. Similar to 
many avian and human influenza viruses, the HPAI H7N7 NL/219 virus was found to be 
resistant to the M2 inhibitor amantadine in a mouse model (Ilyushina et al. 2007). The 
neuraminidase inhibitor oseltamivir was found to be effective against H7N9 virus in mice in 
a dose-dependent manner, with mice protected from death and the emergence of drug-
resistant variants (Baranovich et al. 2013). However, the presence of a lysine at position 292 
of the NA (detected among select H7N9 clinical isolates) resulted in oseltamivir resistance 
without a loss of virulence or transmissibility in vivo (Hai et al. 2013). Oseltamivir has been 
prescribed during H7 influenza outbreaks resulting in conjunctivitis (Koopmans et al. 2004; 
Tweed et al. 2004); in support of this, mice inoculated by the ocular route with HPAI H7N7 
Eurasian lineage or H7N3 North American lineage viruses receiving prophylactic 
oseltamivir treatment exhibited reductions in viral titer in both respiratory and ocular tissues 
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(Belser et al. 2012b). Interference with host cell signaling pathways may also represent a 
possible avenue to attenuate virulence in vivo, as mice treated with morpholino oligomers or 
inhibitors of the JNK or NF-κB pathways exhibited reduced viral loads in the lungs 
following H7N7 virus infection (Gabriel et al. 2008; Haasbach et al. 2013; Nacken et al. 
2012). Serine protease inhibitors have furthermore shown antiviral activity in mice following 
H7N7 challenge (Bahgat et al. 2011). The successful use of convalescent plasma for the 
treatment of human H5N1 infection has indicated that passive immunotherapy warrants 
further investigation as a therapeutic agent (Zhou et al. 2007); monoclonal antibodies with 
neutralizing activity against H7 viruses have increased survival and limited virus replication 
in mice following lethal H7 virus challenge, indicating that antibody-based therapy, 
administered either prophylactically or as a treatment, could provide an additional approach 
to contain the spread of a pandemic H7 virus in the absence of an effective vaccine (Ekiert et 
al. 2011; He et al. 2013).
6 Conclusions
Influenza viruses within the H7 subtype have caused a broad spectrum of human infection, 
from conjunctivitis and mild influenza-like illness to severe disease, acute respiratory 
distress syndrome, and death. The viruses responsible for these human infections have 
similarly demonstrated a wide range of virulence and transmissible phenotypes in 
mammalian models (Table 1). This diversity highlights that there is no one “representative” 
H7 strain and that laboratory study of this subtype necessitates the inclusion of multiple 
isolates to identify and control for strain-specific differences. Just as mammalian models for 
the study of H7 virus pathogenesis and transmission have become more refined to better 
address specific questions pertinent to this virus subtype, such as investigating the apparent 
ocular tropism frequently associated with this virus subtype in humans, the development and 
evaluation of both existing and nascent vaccines and antiviral treatments must be attuned to 
the different manifestations of disease possible following human infection with this subtype. 
There is a need for continued analysis of the clinical relevance of mutations present among 
H7 viruses which confer a resistant phenotype in vitro, especially as they pertain to viral 
fitness and transmissibility (Sleeman et al. 2013). The frequent interspecies transmission of 
Eurasian and North American H7 viruses from aquatic birds to poultry, and detection of a 
poultry-like receptor binding site among contemporary viruses within this subtype, indicates 
that this subtype readily infects gallinaceous poultry and underscores both the need for 
continued surveillance of this virus subtype and preparation for future cases of human 
infection (Gambaryan et al. 2012). Collectively, these studies show the continued 
requirement for the study of H7 viruses and the con-current reminder to use personal 
protective equipment that includes both respiratory and eye protection in all instances of 
potential laboratory or occupational exposure to LPAI and HPAI H7 viruses (Morgan et al. 
2009).
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Fig. 1. 
Diversity of emerging influenza viruses associated with human infection. Confirmed or 
presumed (serologic evidence only) cases of avian influenza virus infection in humans since 
1996. *, includes cases with serologic evidence only. Red border surrounding H5N1 human 
cases from 2003 to present indicates that there is substantial clade-specific and geographic 
diversity among this virus subtype not represented in this image (Abdel-Ghafar et al. 2008)
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Fig. 2. 
Contribution of receptor binding preference on virus transmissibility in the ferret model. 
Virus receptor binding is depicted as maintaining a strong avian binding preference (three 
α2-3 icons), maintaining an avian binding preference with detectable binding to human 
receptors (two α2-3 icons, one α2-6 icon), enhanced binding to human receptors while 
maintaining binding to avian receptors (two α2-6 icons, one α2-3 icon) or strong human 
binding preference (three α2-6 icons) and is not meant to be quantitative. “DC transmission” 
indicates one inoculated ferret and one naïve ferret co-housed in the same cage, sharing 
food, water, and bedding; “RD transmission” indicates one inoculated ferret and one naïve 
ferret housed in adjacent cages separated by a perforated side-wall (3–5 mm in diameter) 
allowing air exchange only in the absence of direct or indirect contact
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